中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Huang, Shuang;  Chen, Xiaozhong;  Qu, Song;  Qu, Shenhong;  Han, Yaqian;  Yang, Kunyu;  Huang, Shiting;  Li, Min;  Zhang, Lin;  Ding, Qian
收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yang, Yunpeng;  Zhao, Yuangyuan;  Zhou, Ting;  Chen, Gang;  Huang, Yan;  Liu, Feng;  Liu, Zhigang;  Qu, Song;  Lei, Yu;  Chen, Xiaozhong;  Lin, Lizhu;  Fu, Zhichao;  Zhang, Xiaojing;  Yang, Zeyu;  Huang, Chuanpei;  Zhang, Li
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Sun, Yan;  Hu, Chaosu;  Lin, Qin;  Gao, Li;  Wang, Jianhua;  Zhu, Xiaodong;  Hao, Junfang;  Lang, Jin Yi;  Wang, Peiguo;  Ye, Ming;  Li, Xia;  Xu, Benhua;  Wu, Rong;  Bai, Chunmei;  You, Qingshan;  Chen, Xiaozhong;  Wang, Jun;  Hu, Desheng;  Wu, Gang;  Pan, Jian-Ji
收藏  |  浏览/下载：31/0  |  提交时间：2022/12/23
Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Jiang, Feng;  Chen, Xiaozhong;  Liu, Tongxin;  Qin, WeiFeng;  Huang, Shuang;  Cao, Caineng;  Jin, Ting;  Jin, Qifeng
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23